Medical Properties Trust Inc. common stock (MPT)

FairStock Score: 74/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I see Medical Properties Trust as a hospital landlord: 373 facilities and about 38,000 licensed beds, net-leased to operators. That can be a decent business when tenants pay, but the filed record shows how quickly operator stress can hit the landlord. FY2024 was a $2.4 billion net loss with diluted EPS of -$4.02, and FY2025 still lost $277.0 million, or -$0.46 per diluted share. The latest filed quarter, fiscal Q1 2026 ended 2026-03-31, was better: revenue of $252.1 million, net income of $32.8 million and EPS of $0.05, against revenue of $223.8 million in fiscal Q1 2025 ended 2025-03-31. So there is a turnaround, but it is not yet proven. At the $2.80 close on 2026-10-26, FairStock's P/B is 0.37 and P/E is -56.00; the negative P/E is meaningless with losses. Debt is heavy at D/E 2.16, Altman Z is -0.22 and Piotroski is 4/9, all FairStock calculations. The 10.59% dividend yield and 13.5% TTM FCF yield look attractive, but FFO/AFFO, the right REIT measures, are not in the data, so I lean on leverage, revenue trend and price-to-book. The Lynch category is TURNAROUND because the latest year had a loss after earlier profits. Cheap can be a trap when balance sheets are stretched.

In plain English: Medical Properties Trust owns hospital buildings and leases them to hospital operators. The business looks weak: it has had big losses, heavy borrowing, and only a small recent profit, though revenue has been rising. At $2.80, the price looks low compared with the accounting value of its assets, but the high dividend may be risky.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-26 close · note generated 2026-10-28 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · fiscal Q1 2025 10-Q (period ended 2025-03-31) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer